Contact this trialFirst, we need to learn more about you.
Alkylating Agent
Chemotherapy +/− Infigratinib for Bile Duct Cancer
Recruiting1 awardPhase 2
Atlanta, Georgia
This trial is testing if it's safe to give targeted therapy and chemotherapy before surgery to patients with a certain kind of liver cancer.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.